Skip to search.
 TSX Up0.64% TSX Ventures 0.00%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM

32.54 Up 1.11(3.53%) Jun 18, 4:00PM EDT|After Hours : 32.54 0.00 (0.00%) Jun 18, 4:31PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending2012-12-302011-12-302010-12-30
Total Revenue 31,388   30,037   23,538  
Cost of Revenue3,601  4,909   -  
Gross Profit 27,787   25,128   23,538  
Operating Expenses
Research Development10,790  10,291  22,067  
Selling General and Administrative16,108  13,275  11,127  
Non Recurring315  2,260  19,648  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 574   (698) (29,304)
Income from Continuing Operations
Total Other Income/Expenses Net(1,134)(383)13,519  
Earnings Before Interest And Taxes(3,865)(3,558)(15,403)
Interest Expense -   -   -  
Income Before Tax(3,865)(3,558)(15,403)
Income Tax Expense(1,191)(13,270)(2,617)
Minority Interest -   -   -  
Net Income From Continuing Ops(2,674)9,712  (12,786)
Non-recurring Events
Discontinued Operations2,147  3  2,413  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (527) 9,715   (10,373)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (527) 9,715   (10,373)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.